Study period | ||||||
---|---|---|---|---|---|---|
Enrolment | Baseline | Allocation | Intervention | Post-intervention | Follow-up | |
Timepoint (weeks) | − 1 | 0 | 0 | 0 | 1 | 5 |
Enrolment: | ||||||
Eligibility screen | X | |||||
Informed consent | X | |||||
Allocation | X | |||||
Interventions | ||||||
Experimental group | ↔ | |||||
Control group | ↔ | |||||
Assessments: | ||||||
Demographics | X | |||||
Use of technological solutions and VR | X | |||||
Level of exposure to COVID-19 | X | |||||
FCOR | X | |||||
Stress and anxiety management | X | |||||
PSS-10 | X | X | X | |||
STAI-Y2 | X | X | X | |||
DASS-21 | X | X | X | |||
Knowledge of stress and anxiety | X | X | X | |||
STAI-Y1 | X | |||||
VAS-A | X | |||||
SUS | X | |||||
SDM | X | |||||
NPS | X | |||||
Difficulties and adverse effects | X | |||||
Interview | X |